JP2022535323A - プロバイオティクスバイオフィルム組成物およびそれを調製する方法 - Google Patents

プロバイオティクスバイオフィルム組成物およびそれを調製する方法 Download PDF

Info

Publication number
JP2022535323A
JP2022535323A JP2021558510A JP2021558510A JP2022535323A JP 2022535323 A JP2022535323 A JP 2022535323A JP 2021558510 A JP2021558510 A JP 2021558510A JP 2021558510 A JP2021558510 A JP 2021558510A JP 2022535323 A JP2022535323 A JP 2022535323A
Authority
JP
Japan
Prior art keywords
bacteria
biofilm
composition
bacterial
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021558510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535323A5 (cg-RX-API-DMAC10.html
Inventor
ダボウシュ，デビッド
ロズナー，ドリット
コーエン，ステファニー
エリヤフ，ヒラ
Original Assignee
マイバイオティクス ファーマ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/368,030 external-priority patent/US10709744B1/en
Application filed by マイバイオティクス ファーマ リミテッド filed Critical マイバイオティクス ファーマ リミテッド
Publication of JP2022535323A publication Critical patent/JP2022535323A/ja
Publication of JP2022535323A5 publication Critical patent/JP2022535323A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2021558510A 2019-03-28 2020-03-29 プロバイオティクスバイオフィルム組成物およびそれを調製する方法 Pending JP2022535323A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/368,030 US10709744B1 (en) 2019-03-28 2019-03-28 Probiotic biofilm suppositories
US16/368,030 2019-03-28
US201962827931P 2019-04-02 2019-04-02
US62/827,931 2019-04-02
PCT/IL2020/050380 WO2020194319A1 (en) 2019-03-28 2020-03-29 Probiotic biofilm compositions and methods of preparing same

Publications (2)

Publication Number Publication Date
JP2022535323A true JP2022535323A (ja) 2022-08-08
JP2022535323A5 JP2022535323A5 (cg-RX-API-DMAC10.html) 2023-04-05

Family

ID=72610340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021558510A Pending JP2022535323A (ja) 2019-03-28 2020-03-29 プロバイオティクスバイオフィルム組成物およびそれを調製する方法

Country Status (11)

Country Link
EP (1) EP3946392A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022535323A (cg-RX-API-DMAC10.html)
KR (1) KR20220016042A (cg-RX-API-DMAC10.html)
CN (1) CN113766923A (cg-RX-API-DMAC10.html)
AU (1) AU2020250170A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021019437A2 (cg-RX-API-DMAC10.html)
CA (1) CA3131165A1 (cg-RX-API-DMAC10.html)
IL (1) IL286704A (cg-RX-API-DMAC10.html)
MX (1) MX2021011628A (cg-RX-API-DMAC10.html)
SG (1) SG11202110741YA (cg-RX-API-DMAC10.html)
WO (1) WO2020194319A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025532188A (ja) * 2021-09-27 2025-09-29 マイバイオティクス ファーマ リミテッド 微生物組成物、その調製方法およびその使用
CA3247168A1 (en) * 2022-04-05 2023-10-12 Mybiotics Pharma Ltd. BACTERIAL COMPOSITIONS AND METHODS OF CULTURE BACTERIA ON PARTICLES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017516750A (ja) * 2014-03-28 2017-06-22 ディーエスエム アイピー アセッツ ビー．ブイ． カロテノイド産生生物有機体からのカロテノイドの単離プロセス
WO2017203533A1 (en) * 2016-05-25 2017-11-30 Mybiotics Pharma Ltd. Composition and methods for microbiota therapy
WO2018189284A1 (en) * 2017-04-12 2018-10-18 Eth Zurich Consortia of living bacteria useful for treatment of microbiome dysbiosis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2009092810A2 (en) * 2008-01-24 2009-07-30 Bacterfield Oü Single pharmaceutical composition containing antibiotics and probiotics
DE09825657T1 (de) * 2008-11-14 2014-03-13 Unistraw Holdings Pte Ltd. Probiotische Zusammensetzungen, Verfahren und Vorrichtung zu ihrer Verabreichung
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
EP3536168A3 (en) * 2014-03-06 2019-10-16 The Research Institute at Nationwide Children's Hospital Probiotic formulations and methods for use
CA2985729C (en) * 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
AU2016353091B2 (en) * 2015-11-10 2022-07-14 Probiotech Llc Probiotic delivery systems
WO2017095968A1 (en) * 2015-11-30 2017-06-08 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
US11297868B2 (en) * 2016-05-29 2022-04-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Method of generating bacterial compositions
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
WO2019136391A1 (en) * 2018-01-05 2019-07-11 Human Longevity, Inc. Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017516750A (ja) * 2014-03-28 2017-06-22 ディーエスエム アイピー アセッツ ビー．ブイ． カロテノイド産生生物有機体からのカロテノイドの単離プロセス
WO2017203533A1 (en) * 2016-05-25 2017-11-30 Mybiotics Pharma Ltd. Composition and methods for microbiota therapy
WO2018189284A1 (en) * 2017-04-12 2018-10-18 Eth Zurich Consortia of living bacteria useful for treatment of microbiome dysbiosis

Also Published As

Publication number Publication date
MX2021011628A (es) 2021-12-10
EP3946392A4 (en) 2022-12-07
CA3131165A1 (en) 2020-10-01
WO2020194319A1 (en) 2020-10-01
KR20220016042A (ko) 2022-02-08
CN113766923A (zh) 2021-12-07
EP3946392A1 (en) 2022-02-09
BR112021019437A2 (pt) 2021-11-30
IL286704A (en) 2021-10-31
AU2020250170A1 (en) 2021-10-28
SG11202110741YA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
JP7801294B2 (ja) クロストリジウム・ディフィシル感染症の治療における新たな使用
CN116491655B (zh) 益生菌益生元组合物在制备提高肠道益生菌定植的食品中的应用
Rodríguez et al. Antimicrobial properties of probiotic strains isolated from breast-fed infants
Mezzasalma et al. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study
JP6998892B2 (ja) 細菌組成物の作製方法
CN111088178A (zh) 一种产乳酸和h2o2的乳杆菌及其应用
Jamyuang et al. Characterization and probiotic properties of Lactobacilli from human breast milk
CA3027917A1 (en) Treatment of clostridium difficile infection
VidyaLaxme et al. Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties
CN105193860A (zh) 人工培养阴道菌群移植在妇科炎症中的应用方法
TW202034776A (zh) 長雙歧桿菌長亞種、含其的組合物及用途
Liu et al. Probiotics alleviate inflammatory bowel disease in mice by regulating intestinal microorganisms-bile acid-NLRP3 inflammasome pathway.
WO2015140299A1 (en) Oronasopharyngeal probiotics
CN120158394A (zh) 一种长双歧杆菌长亚种fn103及其组合物
EP3972619A1 (en) Composition for treatment, alleviation or prophylaxis of acne
KR20220016042A (ko) 프로바이오틱 생물막 조성물 및 이의 제조 방법
AU2016305391A1 (en) Novel Lactobacillus sp. microorganisms, and composition for animal feed comprising same
US20200338137A1 (en) Probiotic biofilm suppositories
US10709744B1 (en) Probiotic biofilm suppositories
JP7179328B2 (ja) 経口投与用の皮膚用保湿機能剤
CN119552773A (zh) 一种卷曲乳杆菌m58d及其组合物
US20220154134A1 (en) Probiotic biofilm compositions and methods of preparing same
JP2025526081A (ja) ラクチプランチバチルス・プランタルム株とその使用
CN110279118B (zh) 一种复合益生菌组合物、复合益生菌冻干粉胶囊及制备方法
US20250270536A1 (en) Bacterial compositions and methods for growing bacteria on particles

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240220

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240517

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241008